These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25944292)

  • 41. Validation of the OMNI vocal effort scale in the treatment of adductor spasmodic dysphonia.
    Shoffel-Havakuk H; Marks KL; Morton M; Johns MM; Hapner ER
    Laryngoscope; 2019 Feb; 129(2):448-453. PubMed ID: 30315575
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Differential diagnosis of muscle tension dysphonia and spasmodic dysphonia.
    Roy N
    Curr Opin Otolaryngol Head Neck Surg; 2010 Jun; 18(3):165-70. PubMed ID: 20389245
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Abnormal activation of the primary somatosensory cortex in spasmodic dysphonia: an fMRI study.
    Simonyan K; Ludlow CL
    Cereb Cortex; 2010 Nov; 20(11):2749-59. PubMed ID: 20194686
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Adductor spasmodic dysphonia and muscular tension dysphonia: acoustic analysis of sustained phonation and reading.
    Sapienza CM; Walton S; Murry T
    J Voice; 2000 Dec; 14(4):502-20. PubMed ID: 11130109
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Differential diagnosis of muscle tension dysphonia and adductor spasmodic dysphonia using spectral moments of the long-term average spectrum.
    Houtz DR; Roy N; Merrill RM; Smith ME
    Laryngoscope; 2010 Apr; 120(4):749-57. PubMed ID: 20222024
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Proposal for a Core Outcome Set of Measurement Instruments to Assess Quality of Voice in Adductor Spasmodic Dysphonia Based on a Literature Review.
    Schuering JHC; van Hof KS; Heijnen BJ; van Benthem PPG; Sjögren EV; Langeveld APM
    J Voice; 2021 Nov; 35(6):933.e7-933.e21. PubMed ID: 32234360
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effects of voicing and syntactic complexity on sign expression in adductor spasmodic dysphonia.
    Erickson ML
    Am J Speech Lang Pathol; 2003 Nov; 12(4):416-24. PubMed ID: 14658993
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential vibratory characteristics of adductor spasmodic dysphonia and muscle tension dysphonia on high-speed digital imaging.
    Patel RR; Liu L; Galatsanos N; Bless DM
    Ann Otol Rhinol Laryngol; 2011 Jan; 120(1):21-32. PubMed ID: 21370677
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Acoustic variations in reading produced by speakers with spasmodic dysphonia pre-botox injection and within early stages of post-botox injection.
    Sapienza CM; Cannito MP; Murry T; Branski R; Woodson G
    J Speech Lang Hear Res; 2002 Oct; 45(5):830-43. PubMed ID: 12381042
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Predictive value and discriminant capacity of cepstral- and spectral-based measures during continuous speech.
    Lowell SY; Colton RH; Kelley RT; Mizia SA
    J Voice; 2013 Jul; 27(4):393-400. PubMed ID: 23684735
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Long-term voice handicap index after type II thyroplasty using titanium bridges for adductor spasmodic dysphonia.
    Sanuki T; Yumoto E; Kodama N; Minoda R; Kumai Y
    Auris Nasus Larynx; 2014 Jun; 41(3):285-9. PubMed ID: 24369905
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Voice disorders in the workplace: productivity in spasmodic dysphonia and the impact of botulinum toxin.
    Meyer TK; Hu A; Hillel AD
    Laryngoscope; 2013 Nov; 123 Suppl 6():S1-14. PubMed ID: 23818277
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Acoustic analyses of thyroidectomy-related changes in vowel phonation.
    Solomon NP; Awan SN; Helou LB; Stojadinovic A
    J Voice; 2012 Nov; 26(6):711-20. PubMed ID: 23177742
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Voice Onset Time in Children With and Without Vocal Fold Nodules.
    Colletti L; Heller Murray E
    J Speech Lang Hear Res; 2023 May; 66(5):1467-1478. PubMed ID: 36940476
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reliability of High-speed Videoendoscopic Ratings of Essential Voice Tremor and Adductor Spasmodic Dysphonia.
    Parker LA; Kunduk M; Fink DS; McWhorter A
    J Voice; 2019 Jan; 33(1):16-26. PubMed ID: 29246397
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Assessing the effectiveness of botulinum toxin injections for adductor spasmodic dysphonia: clinician and patient perception.
    Braden MN; Johns MM; Klein AM; Delgaudio JM; Gilman M; Hapner ER
    J Voice; 2010 Mar; 24(2):242-9. PubMed ID: 19481417
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The Influence of Linguistic Demand on Symptom Expression in Adductor Spasmodic Dysphonia.
    Froeschke LLO
    J Voice; 2020 Sep; 34(5):807.e11-807.e21. PubMed ID: 31047737
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The Mayo Clinic Arizona Spasmodic Dysphonia Experience: A Demographic Analysis of 718 Patients.
    Patel AB; Bansberg SF; Adler CH; Lott DG; Crujido L
    Ann Otol Rhinol Laryngol; 2015 Nov; 124(11):859-63. PubMed ID: 26024910
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Spectral amplitude measures of adductor spasmodic dysphonic speech.
    Cannito MP; Buder EH; Chorna LB
    J Voice; 2005 Sep; 19(3):391-410. PubMed ID: 16102666
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Abductor paralysis after botox injection for adductor spasmodic dysphonia.
    Venkatesan NN; Johns MM; Hapner ER; DelGaudio JM
    Laryngoscope; 2010 Jun; 120(6):1177-80. PubMed ID: 20513036
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.